Tel 02-816-9315 Fax 02-816-9315 #444 2 Please be informed accordingly, Best regards, Ms. Valarlak Ngamchitcharoen Managing Director ZIGA Innovation Public Company Limited 999/9,10,11 Moo 9 Nai Khlong
marketing with business partners. However, in regards to the current economic situation which is in an improved trend but the risks to asset quality remained in concerns. The Company therefore remains
with business partners. However, in regards to the current economic situation which is in an improved trend but the risks to asset quality remained in concerns. The Company therefore remains cautious in
, in regards to the current economic situation which is in an improved trend but the risks to asset quality remained in concerns. The Company therefore remains cautious in expanding high-risk loans. As
of Modern Pharma Company Limited With regards to the meeting of the Board of Directors of Inter Pharma Public Company Limited, “the Company" No. 4/2020, dated 8th June 2020, resolutions are herebelow
existing shareholders who have subscribed for the ordinary shares in excess of their rights in proportion to their current shareholdings. In this regards, such allocation procedure shall be repeated until
existing shareholders who have subscribed for the ordinary shares in excess of their rights in proportion to their current shareholdings. In this regards, such allocation procedure shall be repeated until
accurate and not misleading. Clause 19. To protect the interest of investors with regards to the information presented to them, the Office may order the securities company under Clause 18 to obtain prior
doing any acts within a specified period of time to ensure that the acknowledgement of information is accurate and not misleading. Clause 19. To protect the interest of investors with regards to the
protect the interest of investors with regards to the information presented to them, the Office may order the securities company under Clause 14 to obtain prior approval for each advertisement. In applying